Gamida Cell Ltd.

GMDADelisted Apr 25, 2024

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001600847

SEC filings (opens in a new tab)

Gamida Cell Ltd. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 52 institutions reported holding it in 13F filings for Q1 2024, worth $697.9K in total; ARK Invest was the only superinvestor holding it.

Q1 2023 vs. Q4 2022

How the institutions holding Gamida Cell Ltd. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of GMDA: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Q1 2023	Change
Holders	55	44	−11
Shares	22.7M	20.8M	−1.94M (−8.5%)
Value	$29.1M	$19.6M	−$9.50M (−32.6%)

New holders (5)

Institutions that held Gamida Cell Ltd. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to GMDA in Q1 2023
Institution	Shares	Value	% of portfolio
Leavell Investment Management, Inc.	138,145	$112.0K	0.01%
Virtu Financial LLC	32,545	$26.0K	0.00%
D. E. Shaw & Co., Inc.	22,340	$18.1K	0.00%
Two Sigma Investments, LP	20,600	$16.7K	0.00%
Sandhill Capital Partners LLC	11,744	$9.51K	0.00%

Sold out (16)

Institutions that held Gamida Cell Ltd. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of GMDA in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Federated Hermes, Inc.	1,547,600	$2.00M
Marshall Wace, LLP	313,207	$404.0K
FNY Investment Advisers, LLC	153,000	$197.0K
Victory Capital Management Inc	105,374	$135.9K
Ergoteles LLC	74,032	$95.5K
Kapitalo Investimentos Ltda	43,900	$56.6K
Goldman Sachs Group Inc	36,876	$47.6K
Citadel Advisors LLC	30,163	$38.9K
Tower Research Capital LLC (TRC)	19,417	$25.0K
Millennium Management LLC	16,602	$21.0K
Creative Planning	12,138	$15.7K
Stifel Financial Corp	12,076	$15.6K
Engineers Gate Manager LP	11,421	$14.7K
Simplex Trading, LLC	2,686	$3.00K
BNP Paribas Arbitrage, SA	772	$996
UBS Group AG	325	$419